Daily Stock List
PharmaCyte Biotech, Inc. (PMCB)
SmallCap Network, Bull Trends, OTCJournal, Shiznit Stocks, Penny Stock General, and SmallCapVoice reported this month on PharmaCyte Biotech, Inc. (PMCB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Silver Spring, Maryland-headquartered PharmaCyte Biotech, Inc. is a clinical stage biotechnology company. It concentrates on developing targeted treatments for cancer and diabetes employing its signature live cell encapsulation technology, Cell-in-a-Box®. This innovative and patented technology is being used as a platform upon which treatments for several types of cancer, including advanced, inoperable pancreatic cancer, and diabetes are being built. PharmaCyte Biotech’s shares trade on the OTCQB.
Additionally, the Company is working towards improving the quality of life of patients with advanced pancreatic cancer and on developing treatments for other types of solid cancerous tumors. PharmaCyte Biotech is ready to head into Phase 2b clinical trials in advanced inoperable pancreatic cancer later in 2015 in Australia.
PharmaCyte Biotech’s treatment for pancreatic cancer involves low doses of the recognized anticancer prodrug ifosfamide, together with encapsulated live cells that convert ifosfamide into its active or "cancer-killing" form. These capsules are placed as close to the cancerous tumor as possible. This is to enable the delivery of the highest levels of the cancer-killing drug at the source of the cancer.
Furthermore, the Company is developing treatments for cancer founded upon chemical constituents of the Cannabis plant, called cannabinoids. It is examining ways to exploit the benefits of Cell-in-a-Box® technology in optimizing the anticancer effectiveness of cannabinoids, while minimizing or outright eliminating the debilitating side effects normally associated with cancer treatments.
The live-cell encapsulation technology utilized by PharmaCyte Biotech is a way to enclose living cells in protective “cocoons” around the size of the head of a pin. The Company encapsulates living cells, not drugs. Each capsule can enclose approximately 10,000 cells. This number can vary depending upon the size of the cells encapsulated.
PharmaCyte Biotech made headlines in the diabetes industry after a study was published that stated its Melligen cell line could produce insulin in diabetic mice. The Company has the exclusive global rights to use the Melligen cells to treat diabetes. Melligen cells are genetically engineered from human liver cells. They have been shown to secrete insulin in response to the concentrations of glucose (blood sugar) in their environment.
In May, PharmaCyte Biotech announced that the Institute of Virology at the University of Veterinary Medicine Vienna, one of the partners in the Company’s international Diabetes Consortium, completed the first round of safety testing of the Melligen cells in mice. The study showed that Melligen cells are as safe as the cells that were encapsulated with the Cell-in-a-Box® technology and then used together with the cancer drug ifosfamide to treat patients with advanced pancreatic cancer in previously conducted clinical trials. This safety study is the first study in animals of the Melligen cells that has been done as part of the work of the international Diabetes Consortium.
Last week, PharmaCyte Biotech announced that it can advance its Cannabis research now that its research partner, The University of Northern Colorado (UNC), successfully obtained a Schedule 1 license from the U.S. Drug Enforcement Agency (DEA). This license will permit PharmaCyte Biotech to continue development of tumor-targeted treatments for serious and deadly cancers through using cannabinoid prodrugs in combination with its signature live-cell encapsulation technology, Cell-in-a-Box®.
PharmaCyte Biotech, Inc. (PMCB), closed Monday's trading session at $0.125, down 0.40%, on 1,414,864 volume with 228 trades. The average volume for the last 60 days is 3,177,806 and the stock's 52-week low/high is $0.095/$0.3348.
Enertopia Corp. (ENRT)
PennyStocks24, MassiveStockProfits, Penny Champions, Penny Dreamers, and Penny Stock General reported earlier on Enertopia Corp. (ENRT), and we choose to highlight the Company as well, here at the QualityStocks Daily Newsletter.
Vancouver, British Columbia-based Enertopia Corp. is concentrating on the growing Canadian Medical Marijuana business opportunity. At present, the Company owns an interest in two separate medical marihuana grow facilities located in Canada. Enertopia is centering on the production, cultivation, and distribution of Medical Marihuana (MMJ) under the new Canadian Federal Government Marihuana for Medical Purposes Regulations (MMPR) Program. Enertopia lists on the OTC Markets Group’s OTCQB.
Enertopia signed a Joint Venture (JV) Agreement with the World of Marihuana Productions Ltd. previously known as 0984321 B.C. Ltd. under the Letter of Intent (LOI) dated November 4, 2013. It can earn up to a 51 percent net revenue interest (NRI) in the JV.
In March 2014, Lexaria Corp. reported that its Board decided to make a strategic entry into the medical marihuana business through an important Joint Venture with Enertopia. Enertopia is engaged in the Lexaria JV in Burlington, Ontario. This facility consists initially of around 30,000 sq. ft., with a right of first refusal having been obtained for another 45,000 sq. ft. totaling 75,000 sq. ft. to accommodate future growth. The Burlington JV has applied to produce 10,000kg of Medical Marihuana annually under its Licensed Producer application.
Enertopia announced the signing of a JV agreement, in February 2014, to acquire up to 75 percent of the Regina, Saskatchewan based scalable, Green Canvas MMJ growing facility. The Green Canvas facility is scalable to 55,000 sq. ft. now undergoing upgrades to make 14,000 sq. ft. production space compliant with MMPR standards.
Enertopia has moved into the health and wellness industry with the launch of its V-Love™ product. V-Love™ does not contain any cannabinoids, as they are illegal in Canada. Nevertheless, Enertopia’s intention is to launch CBD-infused products in jurisdictions where they are legalized in the future. V-Love™ is a sexual gel for women.
This month, Enertopia announced that it signed a binding LOI to sell its wholly-owned sub Thor Pharma Corp along with the MMPR application number 10MMPR0610. The Burlington MMPR license application will continue in the application process under new ownership. The JV could receive up to $1,500,000 in milestone payments upon the Burlington facility becoming licensed under the MMPR program. These funds would be split roughly 50 percent with Lexaria.
Subsequent with this deal, the Burlington JV between Enertopia and Lexaria entered into on May 27, 2014 has been terminated because of the pending sale of the project. The Enertopia and Lexaria Master Joint Venture Agreement entered into on March 5, 2014 is still in good standing. Both companies continue to look at synergistic opportunities to increase shareholder value.
Today, Enertopia announced it signed with London Drugs Ltd. to sell V-Love™ in all their 79 stores across Western Canada. Its initial shipment to the London Drugs main distribution facility in Richmond, British Columbia has been received.
Enertopia Corp. (ENRT), closed Monday's trading session at $0.0207, up 42.76%, on 1,627,418 volume with 209 trades. The average volume for the last 60 days is 188,297 and the stock's 52-week low/high is $0.0126/$0.203.
Bioheart, Inc. (BHRT)
SmallCapVoice, PennyStocks24, Pennybuster, and Energy and Capital reported on Bioheart, Inc. (BHRT), and we report today on the Company, here at the QualityStocks Daily Newsletter.
Bioheart, Inc. is an emerging business in the regenerative medicine/cellular therapy industry. The Company focuses on the discovery, development, and commercialization of cell based therapeutics that prevent, treat, or cure disease through repairing and replacing damaged or aged tissue, cells, and organs, and restoring their normal function. Its discoveries include multiple cell therapies in different stages of development, which repair damaged hearts of patients suffering from chronic and acute heart damage. Bioheart is headquartered in Sunrise, Florida.
The Company’s business includes the development of proprietary cell therapy products and revenue generating physician and patient based regenerative medicine/cell therapy training services, cell collection and cell storage services, the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic.
US Stem Cell Training (SCT) is an operating division of Bioheart. It is a content developer of regenerative medicine/cell therapy informational and training materials for physicians and patients. Additionally, SCT provides in-person and online training courses. Furthermore, SCT provides hands-on clinical application training for physicians and health care professionals interested in providing regenerative medicine/cell therapy procedures.
Vetbiologics (VBI) is an operating division of Bioheart. It is a veterinary regenerative medicine company. VBI’s dedication is to providing veterinarians with the ability to deliver the highest quality regenerative medicine therapies to dogs, cats and horses.
US Stem Cell Clinic, LLC (SCC) is a partially-owned investment of Bioheart. It is a physician run regenerative medicine/cell therapy clinic providing cellular treatments for patients afflicted with neurological, autoimmune, orthopedic and degenerative diseases. SCC isolates stem cells from bone marrow and adipose tissue and also utilizes platelet rich plasma.
Earlier this month, Bioheart announced that it entered into a Letter of Intent (LOI) to acquire Pavillion Scientific, Inc. (Florida) a wholly-owned subsidiary of Pavillion Foods, Inc. (Florida). Pavillion Scientific is the provider of stem cell collection kits to Bioheart and Vetbiologics. Under the terms of the LOI, Pavillion Foods will receive cash, future royalties on a defined number of unit sales, and Bioheart Common Stock warrants to purchase Bioheart Common Stock at a predetermined price. Upon completion of a Definitive Agreement, of which there are no assurances will be completed, Pavillion Scientific will become an operating division of Bioheart.
Bioheart, Inc. (BHRT), closed Monday's trading session at $0.006, up 11.11%, on 5,418,302 volume with 54 trades. The average volume for the last 60 days is 3,896,868 and the stock's 52-week low/high is $0.004/$0.0379.
The Alkaline Water Company, Inc. (WTER)
SmallCapVoice and OTC Markets Group reported earlier on The Alkaline Water Company, Inc. (WTER), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed The Alkaline Water Company, Inc. has developed a unique, state-of-the-art, proprietary electrolysis beverage process that produces healthy alkaline water. This water is packaged and sold in 500ml, 700ml, 1-liter, 3-liter and 1 gallon sizes under the trade name Alkaline88. Alkaline88's premier alkaline water is a pH balanced bottled alkaline drinking water enhanced with trace minerals and electrolytes. The Alkaline Water Company is based in Scottsdale, Arizona.
The Company utilizes an advanced Electrochemically Activated Water (ECA) system to create 8.8 pH drinking water without the use of any chemicals. The ECA process uses specialized electronic cells coated with an assortment of rare earth minerals to produce scientifically engineered water. The design of Alkaline88 is to encourage daily consumption of Alkaline Water through a consumer-oriented bulk delivery system targeted at removing expensive small bottles from the distribution supply chain.
Alkaline88 is produced at an 8.8 pH, intended to obtain optimum body balance. It contains trace Himalayan minerals. The Company incorporated 84 beneficial trace Himalayan minerals to make alkaline88 particularly unique to other pH waters.
This past March, The Alkaline Water Company announced entry into a direct store delivery (DSD) agreement with San Antonio, Texas-based Del Norte Foods, Inc. Del Norte provides DSD services to grocery stores, meat markets, convenience stores, gas stations, pharmacies, as well as retail outlets. Del Norte will be directly delivering Alkaline88 to retailer's shelves. Del Norte will also assist with in-store promotions and inventory tracking and re-ordering.
Last week, The Alkaline Water Company announced multi-chain product placement initiatives at three major retailers in the Upper Midwest region. The new placements include increased product availability across Minnesota and area under the auspices of Cub Foods, which adds Alkaline88 1-liter and 3-liter sizes to its existing 1 gallon product in their Minneapolis stores.
New to Alkaline products is Lunds & Byerlys with 26 strategically located outlets, and also Coborns with 39 locations in Minnesota and South Dakota. This placement at an additional estimated total of 116 retail outlets is forecast to offer premier opportunities to convert hot Midwestern summer weather into increased product sales.
The Alkaline Water Company, Inc. (WTER), closed Monday's trading session at $0.11, up 10.00%, on 490,971 volume with 77 trades. The average volume for the last 60 days is 349,381 and the stock's 52-week low/high is $0.0429/$0.227.
Sigma Labs, Inc. (SGLB)
PennyStocks24 and Pennybuster reported on Sigma Labs, Inc. (SGLB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed Sigma Labs, Inc. engages in the development and commercialization of manufacturing and materials technologies, and research and development (R&D) solutions. It is a leading developer of proprietary In-Process Quality Assurance™ (IPQA®) software for additive manufacturing (AM). Via its wholly-owned subsidiary, B6 Sigma, Inc., Sigma Labs develops and engineers advanced, in-process, non-destructive quality inspection systems for metal-based additive manufacturing. Furthermore, the Company serves as an AM contract manufacturer. Sigma Labs consists of top scientists and engineers from Los Alamos National Laboratory. The Company has its corporate headquarters in Santa Fe, New Mexico.
Sigma Labs concentrates on bringing novel and advanced materials and manufacturing technologies out of the nation's top National Labs and into the marketplace to serve the aerospace, defense, biomedical, power generation, and general industrial sectors. It has current contracts with Federal Government and private industry clients. These contracts are to develop technologies from their conception through the design, building, and testing of prototype systems through integrating sensing, software, materials, and manufacturing technology risk-reduction solutions.
Sigma Labs’ methodology will be to commercialize technologies by way of partnerships, joint development, and licensing with other firms. These technologies include its unique PrintRite3D® technology. This technology will permit metals parts to be built by 3D printing or additive manufacturing with fewer flaws and better properties.
Sigma Labs announced in April 2014 that it signed a Technology Cooperation Agreement with Materialise NV of Leuven, Belgium. The agreement sets out the parties' intention to collaborate technically and commercially in the integration, production, and marketing of PrintRite3D® software-related products for metal-based additive manufacturing. In September 2014, Sigma Labs announced the formal release of its PrintRite3D® INSPECT™ quality assurance software.
In April of this year, Sigma Labs announced the successful completion of its EOS M290 launch event held on April 14, 2015 at its facilities. The M290 AM metal printer is enhanced with the Company’s PrintRite3D® software. It will provide previously-unavailable 3D printing capability, as the Company's technology ensures strict compliance to metallurgical and geometric property specifications.
Regarding financial results for the three months ended March 31, 2015, Sigma Labs Service Revenue for the three months ended March 31, 2015 was approximately $0.2 million, in comparison to approximately $0.1 million for the same period in 2014. It reported a net loss for the three months ended March 31, 2015 of approximately $0.4 million, or $(0.00) per diluted share, in comparison to a loss of approximately $0.5 million, or $(0.00) per diluted share, for Q1 2014.
Sigma Labs, Inc. (SGLB), closed Monday's trading session at $0.07825, down 7.94%, on 1,106,975 volume with 68 trades. The average volume for the last 60 days is 1,447,253 and the stock's 52-week low/high is $0.042/$0.151.
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.0079, up 23.82%, on 49,062,349 volume with 499 trades. The stock’s average daily volume over the past 60 days is 5,839,157, and its 52-week low/high is $0.0008/$0.05.
One World Holdings, Inc. subsidiary The One World Doll Project announced today that it will conduct a stockholders conference call on Wednesday, July 1 at 11:30 AM eastern time. The primary speakers for this call will be Joanne Melton, One World Holdings CEO; and Stacey McBride-Irby, creator of the Prettie Girls! doll line. The call will be moderated by Trent T. Daniel, Founder of The One World Doll Project.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
The One World Doll Project to Give Updates on National Wal-Mart Roll Out and Business Expansion Plans on Quarterly Conference
Fortune Article Highlights The One World Doll Project's Retail Success
Walmart Deal Secured; The One World Doll Project Founder Interviews With CEOLIVE.TV
Cleartronic, Inc. (CLRI)
The QualityStocks Daily Newsletter would like to spotlight Cleartronic, Inc. (CLRI). Today, Cleartronic, Inc. closed trading at $0.07, up 40.00%, on 209,401 volume with 11 trades. The stock’s average daily volume over the past 60 days is 48,112, and its 52-week low/high is $0.04/$0.5499.
Cleartronic, Inc. (CLRI) is a technology holding company that creates and acquires operating subsidiaries to develop, manufacture and sell products, services and integrated systems to government agencies and business enterprises.
VoiceInterop, Inc., a wholly owned subsidiary, is a provider of patented IP communication gateways and communication software. Its gateways are marketed worldwide direct to customers as well as through a network of value added resellers. VoiceInterop has also developed an interoperable communication solution for use by airports. The company markets, installs and supports this interoperability solution directly to airports. International airports currently using the VoiceInterop communication solution include Dulles, Reagan, Omaha, Cincinnati, Green Bay and West Palm Beach.
A recent license agreement provides Cleartronic with the right to market Collabria LLC’s revolutionary ReadyOp™ command, control and communication platform. ReadyOp is a web-based application that integrates multiple databases and a robust communications platform supporting day-to-day activities for planning and managing small- and large-scale events. ReadyOp is designed for fast, efficient access to information and for communication with multiple persons, groups and agencies. ReadyOp is currently being used by numerous federal, state and local government agencies and private enterprises.
Backed by a management team committed to growing its business and finding ways to create value for shareholders, Cleartronic is well-positioned to grow in a broad array of markets. The company has a solid business plan in place that maximizes available resources for accelerated growth and has proven its ability to identify strong business opportunities. Disclaimer
Cleartronic, Inc. Company Blog
Cleartronic, Inc. News:
Cleartronic, Inc. (CLRI) Begins Nationwide Retail Store Project
Cleartronic, Inc. (CLRI) Subsidiary Signs Agreement with Houston-Galveston Area Council
Cleartronic, Inc. (CLRI) on the "Your Monies Worth" Show
Dominovas Energy Corp. (DNRG)
The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.0069, up 23.21%, on 777,185 volume with 29 trades. The stock’s average daily volume over the past 60 days is 925,188 and its 52-week low/high is $0.0035/$0.45.
Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.
At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.
In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.
Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer
Dominovas Energy Corp. Blog
Dominovas Energy Corp. News:
Dominovas Energy Enters Second Power Provider Agreement in the Democratic Republic of the Congo
Dominovas Energy Signs Multi-Megawatt Agreement
Dominovas Energy Set for Relaunch With New Branding
WRIT Media Group, Inc. (WRIT)
The QualityStocks Daily Newsletter would like to spotlight WRIT Media Group, Inc. (WRIT). Today, WRIT Media Group, Inc. closed trading at $0.004, even for the day. The stock’s average daily volume over the past 60 days is 259,386, and its 52-week low/high is $0.001/$0.10.
WRIT Media Group, Inc. (WRIT) is focused on expanding in the digital media industry. The holding company currently operates under two different divisions: content creation via Front Row Networks, and "retro" video gaming via Retro Infinity Inc. and Amiga Games Inc.
The company’s Front Row Networks subsidiary produces, acquires and distributes live concerts in 2D and 3D format for initial worldwide digital broadcast into digitally-enabled movie theaters. In addition to presenting live concerts to massive audiences at lower ticket prices, Front Row Networks will license the content for many different distribution channels and sell merchandize where the live concerts are exhibited. The subsidiary also secures and distributes non-concert alternative theatrical programming and aims to acquire the broadest range of rights for exclusive programming.
Retro Infinity specializes in licensing classic computer and console video game libraries and adapts and republishes the most popular titles for smartphones, modern game consoles, micro-consoles, PCs, and tablets. The company leverages platform and classic game brands, coupled with proprietary technologies, to create new revenue from dormant game libraries.
Amiga Games Inc. shares resources with Retro Infinity to adapt and republish the most popular titles from the Amiga family of computers for smartphones, modern game consoles, micro-consoles, PCs, and tablets. WRIT Media Group leverages the Amiga brand along with game brands of the past and proprietary technologies to create new revenue from classic games that have proven their ability to sell very well.
Together with its subsidiaries, WRIT Media Group is well positioned to benefit from the market growth and increased demand for alternative theatrical, mobile, and interactive content. Disclaimer
WRIT Media Group, Inc. Company Blog
WRIT Media Group, Inc. News:
WRIT Media Group Featured in Exclusive QualityStocks Production Video
Retro Infinity Announces Remaining 2014 NASCAR Nationwide Championship Series Events
WRIT Media Group Announces Product Updates and NASCAR Event Recap
The Aristocrat Group Corp. (ASCC)
The QualityStocks Daily Newsletter would like to spotlight The Aristocrat Group Corp. (ASCC). Today, The Aristocrat Group Corp. closed trading at $1.20, off by 11.11%, on 2,757 volume with 19 trades. The stock’s average daily volume over the past 60 days is 838, and its 52-week low/high is $1.00/$7.50.
The Aristocrat Group Corp. (ASCC) is a brand management company specializing in the discovery and promotion of unique brands with mass market appeal. The company strategizes to capitalize on unprecedented brand-building opportunities, and is working to build a portfolio of successful brands to compete alongside industry leaders like Moet Hennessy, Louis Vuitton, Diageo PLC, and Brown-Forman Corp.
Luxuria Brands, an ASCC subsidiary, is tasked with brand management and sustainability, specifically in the beverage alcohol sector, where the company will develop and market brands using strategic, cross-cultural branding initiatives that engage businesses and consumers. Vodka boasts a significantly high market share, accounting for 25 percent of all distilled spirits sold in the United States. What this means for ASCC investors is that they have a remarkable chance to capitalize on a proven commodity and business model for distribution.
To this accord, ASCC's current portfolio of premium luxury goods brands includes top-shelf distilled spirits like RWB Vodka, an ultra-premium handcrafted spirit that has already met remarkable success, including multiple awards. The market for vodka is estimated to be at almost 60 million cases per year in the United States alone, and beverages priced at a premium level are garnering top-dollar returns for businesses and investors. Strategizing to capitalize on this powerful sector, ASCC plans to debut a second lifestyle vodka brand later this year.
ASCC's experienced and visionary management team is committed to creating a solid foundation for innovative technologies and models, ranging from mobile couponing to social engagement, that drive business forward. Building on its established presence in the lucrative beverage alcohol sector, ASCC is emerging as a trusted platform where fledgling ideas turn into commercial successes. Disclaimer
The Aristocrat Group Corp. Company Blog
The Aristocrat Group Corp. News:
ASCC to Enter New Market as a Standout
ASCC Makes Plans to Debut Radical New Distilled Spirit Offering This Summer
ASCC-Sponsored Country Music Star Signs With Award-Winning PR Firm
Today's Top 3
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Aristocrat Group Corp. (ASCC) to Enter New Market as a Standout
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Subsidiary Signs Agreement With Edmonton International Airport
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Enters Second Power Provider Agreement in the Democratic Republic of the Congo
- Galenfeha, Inc. (GLFH) Broadens Oil and Gas Industry Penetration
- Growblox Sciences, Inc. (GBLX) Receives Funding to Complete Construction of Nevada Cultivation Facility
- International Stem Cell Corp. (ISCO) to Present at International Society for Cellular Therapy Annual Meeting
- Loans4Less.com Inc. (LFLS) Enters into an Acquisition Agreement with 321LEND
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International
- One World Holdings, Inc. (OWOO) The One World Doll Project to Give Updates on National Wal-Mart Roll Out and Business Expansion Plans on Quarterly Conference
- Pure Hospitality Solutions, Inc. (PNOW) Releases Oveedia Site Snapshots
- Save The World Air, Inc. (ZERO) Deploys Joule Heat Direct Heating System on Gathering Line for Crude Oil Pipeline in Uintah Basin
- View Systems, Inc. (VSYM) Files for Patent, Begins Manufacturing of Enhanced ViewScan Product
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
- WRIT Media Group, Inc. (WRIT) Featured in Exclusive QualityStocks Production Video